Home / Prazosin / United States
US ATC C02CA01 · updated 2 Nov 2026
Prazosin shortage in United States
Is there a Prazosin shortage in United States?
Yes. As of 2 Nov 2026, 3 Prazosin products are reported short in United States, the first since 28 Apr 2023. No return date has been given. Main reason: not stated.
Also short in Canada, Ireland. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Minipress, Capsule, 1 mg (NDC 0069-4310-71) discontinuation | Pfizer Inc. | 28 Apr 2023 | not given | Not stated |
| US | Minipress, Capsule, 2 mg (NDC 0069-4370-71) discontinuation | Pfizer Inc. | 28 Apr 2023 | not given | Not stated |
| US | Minipress, Capsule, 5 mg (NDC 0069-4380-71) discontinuation | Pfizer Inc. | 28 Apr 2023 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).